China Insulin API Market Report & Forecast 2021-2027

China Insulin API Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Insulin API Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Insulin API Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Insulin API Overall Market Size
2.1 China Insulin API Market Size: 2021 VS 2027
2.2 China Insulin API Revenue, Prospects & Forecasts: 2016-2027
2.3 China Insulin API Sales: 2016-2027
3 Company Landscape
3.1 Top Insulin API Players in China Market
3.2 Top China Insulin API Companies Ranked by Revenue
3.3 China Insulin API Revenue by Companies
3.4 China Insulin API Sales by Companies
3.5 China Insulin API Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Insulin API Companies in China Market, by Revenue in 2020
3.7 Manufacturers Insulin API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Insulin API Players in China Market
3.8.1 List of Tier 1 Insulin API Companies in China
3.8.2 List of Tier 2 and Tier 3 Insulin API Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Insulin API Market Size Markets, 2021 & 2027
4.1.2 Regular Human Insulin
4.1.3 Insulin Analogue
4.2 By Type - China Insulin API Revenue & Forecasts
4.2.1 By Type - China Insulin API Revenue, 2016-2021
4.2.2 By Type - China Insulin API Revenue, 2022-2027
4.2.3 By Type - China Insulin API Revenue Market Share, 2016-2027
4.3 By Type - China Insulin API Sales & Forecasts
4.3.1 By Type - China Insulin API Sales, 2016-2021
4.3.2 By Type - China Insulin API Sales, 2022-2027
4.3.3 By Type - China Insulin API Sales Market Share, 2016-2027
4.4 By Type - China Insulin API Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Insulin API Market Size, 2021 & 2027
5.1.2 Fast-Acting
5.1.3 Premix
5.1.4 Long-Acting
5.2 By Application - China Insulin API Revenue & Forecasts
5.2.1 By Application - China Insulin API Revenue, 2016-2021
5.2.2 By Application - China Insulin API Revenue, 2022-2027
5.2.3 By Application - China Insulin API Revenue Market Share, 2016-2027
5.3 By Application - China Insulin API Sales & Forecasts
5.3.1 By Application - China Insulin API Sales, 2016-2021
5.3.2 By Application - China Insulin API Sales, 2022-2027
5.3.3 By Application - China Insulin API Sales Market Share, 2016-2027
5.4 By Application - China Insulin API Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Overview
6.1.3 Novo Nordisk Insulin API Sales and Revenue in China Market (2016-2021)
6.1.4 Novo Nordisk Insulin API Product Description
6.1.5 Novo Nordisk Recent Developments
6.2 Sanofi-Aventis
6.2.1 Sanofi-Aventis Corporation Information
6.2.2 Sanofi-Aventis Overview
6.2.3 Sanofi-Aventis Insulin API Sales and Revenue in China Market (2016-2021)
6.2.4 Sanofi-Aventis Insulin API Product Description
6.2.5 Sanofi-Aventis Recent Developments
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Overview
6.3.3 Eli Lilly Insulin API Sales and Revenue in China Market (2016-2021)
6.3.4 Eli Lilly Insulin API Product Description
6.3.5 Eli Lilly Recent Developments
6.4 Tonghua Dongbao
6.4.1 Tonghua Dongbao Corporation Information
6.4.2 Tonghua Dongbao Overview
6.4.3 Tonghua Dongbao Insulin API Sales and Revenue in China Market (2016-2021)
6.4.4 Tonghua Dongbao Insulin API Product Description
6.4.5 Tonghua Dongbao Recent Developments
6.5 Ganlee
6.5.1 Ganlee Corporation Information
6.5.2 Ganlee Overview
6.5.3 Ganlee Insulin API Sales and Revenue in China Market (2016-2021)
6.5.4 Ganlee Insulin API Product Description
6.5.5 Ganlee Recent Developments
6.6 United Laboratory
6.6.1 United Laboratory Corporation Information
6.6.2 United Laboratory Overview
6.6.3 United Laboratory Insulin API Sales and Revenue in China Market (2016-2021)
6.6.4 United Laboratory Insulin API Product Description
6.6.5 United Laboratory Recent Developments
6.7 Biocon
6.7.1 Biocon Corporation Information
6.7.2 Biocon Overview
6.7.3 Biocon Insulin API Sales and Revenue in China Market (2016-2021)
6.7.4 Biocon Insulin API Product Description
6.7.5 Biocon Recent Developments
6.8 Amphastar
6.8.1 Amphastar Corporation Information
6.8.2 Amphastar Overview
6.8.3 Amphastar Insulin API Sales and Revenue in China Market (2016-2021)
6.8.4 Amphastar Insulin API Product Description
6.8.5 Amphastar Recent Developments
6.9 Wockhardt
6.9.1 Wockhardt Corporation Information
6.9.2 Wockhardt Overview
6.9.3 Wockhardt Insulin API Sales and Revenue in China Market (2016-2021)
6.9.4 Wockhardt Insulin API Product Description
6.9.5 Wockhardt Recent Developments
6.10 Julphar Diabetes
6.10.1 Julphar Diabetes Corporation Information
6.10.2 Julphar Diabetes Overview
6.10.3 Julphar Diabetes Insulin API Sales and Revenue in China Market (2016-2021)
6.10.4 Julphar Diabetes Insulin API Product Description
6.10.5 Julphar Diabetes Recent Developments
6.11 Torrent Pharma
6.11.1 Torrent Pharma Corporation Information
6.11.2 Torrent Pharma Overview
6.11.3 Torrent Pharma Insulin API Sales and Revenue in China Market (2016-2021)
6.11.4 Torrent Pharma Insulin API Product Description
6.11.5 Torrent Pharma Recent Developments
7 China Insulin API Production Capacity, Analysis
7.1 China Insulin API Production Capacity, 2016-2027
7.2 Insulin API Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Insulin API Supply Chain Analysis
9.1 Insulin API Industry Value Chain
9.2 Insulin API Upstream Market
9.3 Insulin API Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Insulin API Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Insulin API in China Market
Table 2. Top Insulin API Players in China Market, Ranking by Revenue (2019)
Table 3. China Insulin API Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Insulin API Revenue Share by Companies, 2016-2021
Table 5. China Insulin API Sales by Companies, (Kg), 2016-2021
Table 6. China Insulin API Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Insulin API Price (2016-2021) & (K US$/Kg)
Table 8. Manufacturers Insulin API Product Type
Table 9. List of Tier 1 Insulin API Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Insulin API Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Regular Human Insulin
Table 12. Major Manufacturers of Insulin Analogue
Table 13. By Type - China Insulin API Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Insulin API Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Insulin API Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Insulin API Sales (Kg), 2016-2021
Table 17. By Type - China Insulin API Sales (Kg), 2022-2027
Table 18. By Application - China Insulin API Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Insulin API Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Insulin API Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Insulin API Sales (Kg), 2016-2021
Table 22. By Application - China Insulin API Sales (Kg), 2022-2027
Table 23. Novo Nordisk Corporation Information
Table 24. Novo Nordisk Description and Major Businesses
Table 25. Novo Nordisk Insulin API Sales (Kg), Revenue (US$, Mn) and Gross Margin (K US$/Kg) (2016-2021)
Table 26. Novo Nordisk Insulin API Product
Table 27. Novo Nordisk Recent Developments
Table 28. Sanofi-Aventis Corporation Information
Table 29. Sanofi-Aventis Description and Major Businesses
Table 30. Sanofi-Aventis Insulin API Sales (Kg), Revenue (US$, Mn) and Gross Margin (K US$/Kg) (2016-2021)
Table 31. Sanofi-Aventis Insulin API Product
Table 32. Sanofi-Aventis Recent Developments
Table 33. Eli Lilly Corporation Information
Table 34. Eli Lilly Description and Major Businesses
Table 35. Eli Lilly Insulin API Sales (Kg), Revenue (US$, Mn) and Gross Margin (K US$/Kg) (2016-2021)
Table 36. Eli Lilly Insulin API Product
Table 37. Eli Lilly Recent Developments
Table 38. Tonghua Dongbao Corporation Information
Table 39. Tonghua Dongbao Description and Major Businesses
Table 40. Tonghua Dongbao Insulin API Sales (Kg), Revenue (US$, Mn) and Gross Margin (K US$/Kg) (2016-2021)
Table 41. Tonghua Dongbao Insulin API Product
Table 42. Tonghua Dongbao Recent Developments
Table 43. Ganlee Corporation Information
Table 44. Ganlee Description and Major Businesses
Table 45. Ganlee Insulin API Sales (Kg), Revenue (US$, Mn) and Gross Margin (K US$/Kg) (2016-2021)
Table 46. Ganlee Insulin API Product
Table 47. Ganlee Recent Developments
Table 48. United Laboratory Corporation Information
Table 49. United Laboratory Description and Major Businesses
Table 50. United Laboratory Insulin API Sales (Kg), Revenue (US$, Mn) and Gross Margin (K US$/Kg) (2016-2021)
Table 51. United Laboratory Insulin API Product
Table 52. United Laboratory Recent Developments
Table 53. Biocon Corporation Information
Table 54. Biocon Description and Major Businesses
Table 55. Biocon Insulin API Sales (Kg), Revenue (US$, Mn) and Gross Margin (K US$/Kg) (2016-2021)
Table 56. Biocon Insulin API Product
Table 57. Biocon Recent Developments
Table 58. Amphastar Corporation Information
Table 59. Amphastar Description and Major Businesses
Table 60. Amphastar Insulin API Sales (Kg), Revenue (US$, Mn) and Gross Margin (K US$/Kg) (2016-2021)
Table 61. Amphastar Insulin API Product
Table 62. Amphastar Recent Developments
Table 63. Wockhardt Corporation Information
Table 64. Wockhardt Description and Major Businesses
Table 65. Wockhardt Insulin API Sales (Kg), Revenue (US$, Mn) and Gross Margin (K US$/Kg) (2016-2021)
Table 66. Wockhardt Insulin API Product
Table 67. Wockhardt Recent Developments
Table 68. Julphar Diabetes Corporation Information
Table 69. Julphar Diabetes Description and Major Businesses
Table 70. Julphar Diabetes Insulin API Sales (Kg), Revenue (US$, Mn) and Gross Margin (K US$/Kg) (2016-2021)
Table 71. Julphar Diabetes Insulin API Product
Table 72. Julphar Diabetes Recent Developments
Table 73. Torrent Pharma Corporation Information
Table 74. Torrent Pharma Description and Major Businesses
Table 75. Torrent Pharma Insulin API Sales (Kg), Revenue (US$, Mn) and Gross Margin (K US$/Kg) (2016-2021)
Table 76. Torrent Pharma Insulin API Product
Table 77. Torrent Pharma Recent Developments
Table 78. Insulin API Production Capacity (Kg) of Key Manufacturers in China Market, 2019-2021 (Kg)
Table 79. China Insulin API Capacity Market Share of Key Manufacturers, 2019-2021
Table 80. Insulin API Market Opportunities & Trends in China Market
Table 81. Insulin API Market Drivers in China Market
Table 82. Insulin API Market Restraints in China Market
Table 83. Insulin API Raw Materials
Table 84. Insulin API Raw Materials Suppliers in China Market
Table 85. Typical Insulin API Downstream
Table 86. Insulin API Downstream Clients in China Market
Table 87. Insulin API Distributors and Sales Agents in China Market
List of Figures
Figure 1. Insulin API Product Picture
Figure 2. Insulin API Segment by Type
Figure 3. Insulin API Segment by Application
Figure 4. China Insulin API Market Overview: 2020
Figure 5. China Insulin API Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Insulin API Revenue, 2016-2027 (US$, Mn)
Figure 7. Insulin API Sales in China Market: 2016-2027 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Insulin API Revenue in 2020
Figure 9. Regular Human Insulin Product Picture
Figure 10. Insulin Analogue Product Picture
Figure 11. By Type - China Insulin API Sales Market Share, 2016-2027
Figure 12. By Type - China Insulin API Revenue Market Share, 2016-2027
Figure 13. By Type - China Insulin API Price (K US$/Kg), 2016-2027
Figure 14. Fast-Acting
Figure 15. Premix
Figure 16. Long-Acting
Figure 17. By Application - China Insulin API Sales Market Share, 2016-2027
Figure 18. By Application - China Insulin API Revenue Market Share, 2016-2027
Figure 19. By Application - China Insulin API Price (K US$/Kg), 2016-2027
Figure 20. Novo Nordisk Insulin API Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Sanofi-Aventis Insulin API Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Eli Lilly Insulin API Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Tonghua Dongbao Insulin API Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Ganlee Insulin API Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. United Laboratory Insulin API Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Biocon Insulin API Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Amphastar Insulin API Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Wockhardt Insulin API Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Julphar Diabetes Insulin API Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Torrent Pharma Insulin API Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. China Insulin API Production Capacity (Kg), 2016-2027
Figure 32. Insulin API Industry Value Chain
Figure 33. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Metformin Hydrochloride Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......

Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......

Global Insulin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......

Global Insulin API Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Glucagon Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Acarbose Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Insulin Glargine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77

According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......

Global Liraglutide Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103

According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs